Poster Presentations: Tuesday, October 25, 2011 |

Impact of Vancomycin MICs on Critically Ill Patients With MRSA Bacteremia FREE TO VIEW

Christian Woods, MD; Vinay Patel, MD; Anindita Chowdhury, MD; Andrew Shorr, MD
Chest. 2011;140(4_MeetingAbstracts):344A. doi:10.1378/chest.1118312
Text Size: A A A
Published online


PURPOSE: Methicillin-resistant Staphylococcus aureus (MRSA) remains an important pathogen in intensive care unit (ICU) patients. Concern exists that higher, yet still susceptible range, minimum inhibitory concentrations (MICs) for vancomycin (VAN) for MRSA lead to worse outcomes. We sought to determine the effect of an increased VAN MIC on mortality in ICU subjects with MRSA bacteremia.

METHODS: We retrospectively indentified (Jan 2009- Dec 2010) persons diagnosed with MRSA bacteremia and who were concurrently treated in the ICU. Mortality served as the primary endpoint. VAN MICs for the isolates were determined via an automated antibiotic susceptibly testing system (Phoenix). We examined potential confounders including demographics (age, gender), severity of illness (presence of shock, need for mechanical ventilation (MV)), and infection related characteristics (nosocomial vs. non-nosocomial, infection source, eventual development of endocarditis). We employed logistic regression to determine the independent impact of an MIC of 2 µcg/ml on hospital mortality.

RESULTS: The final cohort included 100 subjects and an MIC of 2 µcg/ml occurred in 6.0%. As the MIC increased from 0.5 µcg/ml to 1.0 µcg/ml to 2.0 µcg/ml, hospital morality rates increased from 0% to 34.4% to 83.3%, respectively (p=0.005). Patients infected with MIC of 2 µcg/ml strains were 10.2 times more likely to die while hospitalized (95% CI: 1.1-90.8). Independent correlates of morality included: Age > 65 years, development of endocarditis, shock, need for MV, and an MIC of 2 µcg/ml. The adjusted odds ratio for death associated with and elevated MIC equaled 20.96 (95% CI: 1.84-238.56, p=0.014).

CONCLUSIONS: Elevated MICs to VAN in MRSA bacteremia among critically ill subjects occur infrequently. However an MIC of 2 µcg/ml, while technically representing susceptibility to VAN, confers an elevated risk for mortality.

CLINICAL IMPLICATIONS: Monitoring and reporting of the MICs of MRSA to VAN may be important in critically ill patients. Alternative agents other than VAN merit evaluation for MRSA bacteremia, particularly in cases where the MIC of MRSA to VAN is 2 µcg/ml.

DISCLOSURE: Andrew Shorr: Consultant fee, speaker bureau, advisory committee, etc.: Andrew SHorr recived consultant fees from Phizer, Theravance, Forrest, Astellas, and Trius., Consultant fee, speaker bureau, advisory committee, etc.: Andrew SHorr is on the speak bureau for Phizer., Grant monies (from industry related sources): Andrew SHorr has received grant money from Phizer and Astellas.

The following authors have nothing to disclose: Christian Woods, Vinay Patel, Anindita Chowdhury

No Product/Research Disclosure Information

09:00 AM - 10:00 AM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Antibiotic prophylaxis for GI endoscopy.
American Society for Gastrointestinal Endoscopy | 11/28/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543